Abstract
With the exception of various central nervous system (CNS)-required nutrients for which specific, saturable transport systems exist, the passage of most water-soluble solutes through the blood–brain barrier (BBB) is believed to depend largely on the lipid solubility of the solutes. Most peptides, therefore, do not enter the CNS because of their hydrophilic character. Recently, utilizing homologous series of model peptides and Caco-2 cell monolayers as a model of the intestinal mucosa, it was concluded that the principal determinant of peptide transport across the intestinal cellular membrane is the energy required to desolvate the polar amide bonds in the peptide (P. S. Burton et al., Adv. Drug Deliv. Rev. 7:365–386, 1991). To determine whether this correlation can be extended to the BBB, the permeabilities of the same peptides were determined using an in vitro as well as an in situ BBB model. The peptides, blocked on the N- and C-terminal ends, consisted of D-phenylalanine (F) residues: AcFNH2, AcF2NH2, AcF3NH2, AcF2(NMeF)NH2, AcF(NMeF)2NH2, Ac(NMeF)3NH2, and Ac(NMeF)3NHMe. A good correlation among the permeabilities of these model peptides across the bovine brain microvessel endothelial cell (BBMEC) monolayers, an in vitro model of the BBB, and their permeabilities across the BBB in situ was observed (r = 0.928, P < 0.05). The permeabilities of these peptides did not correlate with the octanol–buffer partition coefficients of the peptides (r = 0.389 in vitro and r = 0.155 in situ; P < 0.05). However, correlations were observed between the permeabilities of these peptides and the number of potential hydrogen bonds the peptides can make with water (r = 0.837 in vitro and r = 0.906 in situ; P < 0.05), suggesting that desolvation of the polar bonds in the molecule is a determinant of permeability. Consistent with this, good correlations were found between the permeabilities of these peptides and their partition coefficients between heptane–ethylene glycol (r = 0.981 in vitro and r = 0.940 in situ ; P < 0.05) or the differences in partition coefficients between octanol–buffer and isooctane–buffer (ΔlogPC) (r = 0.961 in vitro and r = 0.962 in situ; P < 0.05), both of which are experimental estimates of hydrogen bond or desolvation potential. These results suggest that the permeability of peptides through the BBB is governed by the same physicochemical parameter (hydrogen bonding potential) as their permeability through the intestinal mucosa.
Similar content being viewed by others
REFERENCES
G. W. Goldstein and A. L. Betz. The blood-brain barrier. Sci. Am. 255:74–83 (1986).
W. M. Pardridge. Receptor-mediated transport through the blood-brain barrier. Endocr. Rev. 7:314–330 (1986).
M. W. Brightman. Morphology of the blood-brain barrier. Exp. Eye Res. Suppl. 1–25 (1977).
T. S. Reese and M. J. Karnovsky. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34:207–217 (1967).
S. I. Rapoport. In S. I. Rapoport (ed.), Blood Brain Barrier in Physiology and Medicine, Raven Press, New York, 1976, pp. 153–176.
K. L. Audus, P. J. Chikhale, D. W. Miller, S. E. Thompson, and R. T. Borchardt. Brain uptake of drugs: The influence of chemical and biological factors. Adv. Drug Res. 23:1–64 (1992).
Y. Takakura, K. L. Audus, and R. T. Borchardt. Blood-brain barrier: Transport studies in isolated brain capillaries and in cultured brain endothelial cells. Adv. Pharmacol. 22:137–165 (1991).
R. A. Conradi, A. R. Hilgers, N. F. H. Ho, and P. S. Burton. The influence of peptide structure on transport across Caco-2 cells. Pharm. Res. 8:1453–1460 (1991).
R. A. Conradi, A. R. Hilgers, N. F. H. Ho, and P. S. Burton. The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm. Res. 9:435–439 (1992).
P. S. Burton, R. A. Conradi, and A. R. Hilgers. Mechanisms of peptide and protein absorption. (2) Transcellular mechanism of peptide and protein absorption: passive aspects. Adv. Drug Del. Rev. 7:365–386 (1991).
P. Seiler. Interconversion of lipophilicities from the hydrogen/water systems into the octanol/water system. Eur. J. Med. Chem. 9:474–479 (1974).
P. S. Burton, R. A. Conradi, A. R. Hilgers, N. F. H. Ho, and L. L. Maggiora. The relationship between peptide structure and transport across epithelial cell monolayers. J. Control. Release 19:87–98 (1992).
K. L. Audus and R. T. Borchardt. Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm. Res. 3:81–87 (1986).
Y. Takasato, S. I. Rapoport, and Q. R. Smith. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247:H484–H493 (1984).
K. Y. Ng, D. W. Miller, A. Kato, and R. T. Borchardt. An improved in vitro model of the blood-brain barrier for determining macromolecule transport into the brain (in preparation).
L. L. Rubin, D. E. Hall, S. Porter, K. Barbu, C. Cannon, H. Horner, M. Janatpour, C. W. Liaw, K. Manning, J. Morales, L. I. Tanner, K. J. Tomasell and F. Bard. A cell culture model of the blood-brain barrier. J. Cell Biol. 115:1725–1735 (1992).
N. F. H. Ho, J. Y. Park, P. F. Ni, and W. I. Higuchi. Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies in animals and humans. In W. Crouthamel and A. C. Sugars (eds). Animal Models for Oral Drug Delivery in Man, Am. Pharm. Assoc., Washington, DC, 1983, pp. 27–106.
K. Ng, G. Grass, H. Lane, and R. T. Borchardt. Characterization of the unstirred water layer in cultured brain microvessel endothelial cells. In Vitro Cell. Dev. Biol. 29A:627–629 (1993).
K. Ohno, K. D. Pettigrew, and S. I. Rapoport. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol. 235:H299–H307 (1978).
Q. R. Smith. Quantitation of blood-brain barrier permeability. In E. A. Neuwelt (ed.), Implications of the Blood-Brain Barrier and Its Manipulation, Vol. 1, Plenum Press, New York, 1989, pp. 85–118.
S. Fukiu, R. Schwarcs, S. I. Rapoport, Y. Takada, and Q. R. Smith. Blood-brain barrier transport of kynurenines: Implications for brain synthesis and metabolism. J. Neurochem. 56:2007–2017 (1991).
C. Crone and D. G. Levitt. Capillary permeability to small solutes. In E. M. Renkin and C. C. Michel (eds.), Handbook of Physiology, Section 2: The Cardiovascular System, Vol. 4. Microcirculation, Part 1, American Physiological Society, Bethesda, MD, 1984, pp. 411–466.
H. Metzer, S. Heuber-Metzer, A. Steinacker, and J. Struber. Staining PO2 measurement sides in the rat brain and quantitative morphometry of the surrounding capillaries. Pfleugers Arch. 388:21–27 (1980).
R. R. Sokal and F. J. Rohlf (eds.). Biometry, W. H. Freeman, New York, 1981, pp. 583–591.
F. J. Rohlf and R. R. Sokal (eds.). Statistical Tables, W. H. Freeman, New York, 1981, pp. 61–63, 80–81, 166–168.
S. Momma, M. Aoyagi, S. I. Rapoport, and Q. R. Smith. Phenylalanine transport across the blood-brain barrier studied with the in situ brain perfusion technique. J. Neurochem. 48:1291–1300 (1987).
M. D. Josten. Hydrogen bonding and proton transfer. J. Chem. Ed. 59:362–366 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chikhale, E.G., Ng, KY., Burton, P.S. et al. Hydrogen Bonding Potential as a Determinant of the in Vitro and in Situ Blood–Brain Barrier Permeability of Peptides. Pharm Res 11, 412–419 (1994). https://doi.org/10.1023/A:1018969222130
Issue Date:
DOI: https://doi.org/10.1023/A:1018969222130